Increases Buying Power with New $900 Million Credit Facility and
$300 Million Senior Notes Offering
BIRMINGHAM, Ala.--(BUSINESS WIRE)--Aug. 7, 2014--
Medical Properties Trust, Inc. (the “Company” or “MPT”) (NYSE: MPW)
today announced financial and operating results for the second quarter
ended June 30, 2014.
SECOND QUARTER AND RECENT HIGHLIGHTS
-
Achieved second quarter Normalized Funds from Operations (“FFO”) per
diluted share of $0.26, up 8% compared with $0.24 per diluted share
reported in the second quarter of 2013; year to date Normalized FFO of
$0.52 per diluted share also represents 8% increase over 2013;
-
Completed and commenced collection of rent from six First Choice ER
facilities (for a total of nine operating facilities with nine more
under construction);
-
Executed a new binding agreement for an additional $150 million
commitment to develop multiple facilities with First Choice’s parent
company, Adeptus Health, aggregating $250 million in development
funding to Adeptus;
-
Entered the vibrant UK healthcare market by acquiring the real estate
of a recently constructed acute care hospital in the city of Bath,
approximately 100 miles west of London, from Circle Health Ltd. for
₤29.4 million (approximately $49.9 million) and leased back the
facility to Circle Hospital (Bath) in a 15-year lease with a tenant
option to extend the lease for an additional 15 years;
-
Completed a new $900 million senior unsecured credit facility that is
expected to significantly decrease the Company’s interest expense and,
along with the $300 million of proceeds from the previously announced
offering in April of unsecured senior notes, will provide
substantially greater resources for anticipated acquisitions of
hospital real estate.
Included in the financial tables accompanying this press release is
information about the Company’s assets and liabilities, net income and
reconciliations of net income to FFO and Adjusted Funds from Operations
(AFFO), all on a comparable basis to 2013 periods.
“Medical Properties Trust is a forward-thinking company that devotes
substantial resources to carefully studying the healthcare landscape and
making investment decisions based on that intelligence,” said Edward K.
Aldag, Jr., Chairman, President and CEO Medical Properties Trust. “Our
relationship with Adeptus is a good example; together, MPT and Adeptus
have considerably increased neighborhood access to emergency care
through free-standing emergency rooms. With MPT’s financing model,
Adeptus was able to grow at a strong and consistent pace, avoiding
having to access expensive equity markets until it had built a
successful business on its own. Our agreement to fund its next $150
million in development is an affirmation of the degree to which MPT has
enabled Adeptus to become a leading name in healthcare innovation, and
unlock impressive growth in the process.”
“Similarly, we are also delighted to have expanded our Western European
footprint into the UK with a reputable and innovative healthcare
provider like Circle Health. The company’s strategies of clinician
partnerships and collaboration with the government funded National
Health Service bodes well for future growth not only for Circle but the
UK hospital business as a whole. We expect new opportunities will
continue to emerge in the region and that the sale/leaseback financing
model that MPT pioneered for hospitals in the U.S. will be increasingly
adopted by hospital operators in the UK and other stable economies.
While we expect the U.S. to remain our core market for hospital
investments, we see significant opportunity to make accretive
acquisitions that will help to diversify our portfolio and expand our
FFO internationally.”
OPERATING RESULTS
Second quarter 2014 total revenues increased 34% to $76.6 million
compared with $57.1 million for the second quarter of 2013. Normalized
FFO for the quarter increased 24% to $44.5 million compared with $35.9
million in the second quarter of 2013. Per share Normalized FFO
increased 8% to $0.26 per diluted share in the second quarter of 2014
compared with $0.24 per diluted share in the second quarter of 2013.
Excluded from Normalized FFO was the effect of previously disclosed
impairments of $29.6 million (or $0.17 per diluted share) related to
Monroe Hospital in Bloomington, Indiana and the Bucks County Hospital in
Pennsylvania. As a result, we incurred a net loss for the second quarter
of 2014 of $0.2 million (or $--- per diluted share) compared with
earning net income of $27.3 million (or $0.18 per diluted share) in the
second quarter of 2013.
For the first six months of 2014, Normalized FFO per diluted share
increased 8% to $0.52 compared to $0.48 for the first six months of
2013. Revenue for the first six months of 2014 increased 30% to $149.6
million from $114.7 million in the first six months of 2013.
PORTFOLIO UPDATE AND OUTLOOK
As of June 30, 2014, the Company had total real estate and related
investments of approximately $3.0 billion comprised of 118 healthcare
properties in 25 states and in Germany. The properties are leased to or
mortgaged by 27 hospital operating companies. Based solely on this
portfolio, the transactions described herein that occurred subsequent to
June 30, 2014 and the acquisition of additional but unidentified
acquisitions that have initial yields of between 8.0% and 11.0%, the
annual run rate for Normalized FFO per share is expected to range from
$1.10 to $1.14. Actual 2014 Normalized FFO will differ from this range
and the Company will provide periodic updates as acquisitions are
finalized.
The annualized run-rate guidance estimate does not include the effects,
if any, of real estate operating costs, litigation costs, debt
refinancing costs, acquisition costs, interest rate hedging activities,
write-offs of straight-line rent or other non-recurring or unplanned
transactions. These estimates will change if the Company acquires assets
totaling more or less than its expectations, the timing of acquisitions
varies from expectations, capitalization rates vary from expectations,
market interest rates change, debt is refinanced, new shares are issued,
additional debt is incurred, assets are sold, other operating expenses
vary, income from investments in tenant operations vary from
expectations, or existing leases do not perform in accordance with their
terms.
CONFERENCE CALL AND WEBCAST
The Company has scheduled a conference call and webcast for Thursday,
August 7, 2014 at 11:00 a.m. Eastern Time to present the Company’s
financial and operating results for the quarter ended June 30, 2014. The
dial-in numbers for the conference call are 877-546-5019 (U.S.) and
857-244-7551 (international); both numbers require passcode 31764608.
The conference call will also be available via webcast in the Investor
Relations’ section of the Company’s website, www.medicalpropertiestrust.com.
A telephone and webcast replay of the call will be available beginning
shortly after the call’s completion through August 21, 2014. Dial-in
numbers for the replay are 888-286-8010 and 617-801-6888 for U.S. and
International callers, respectively. The replay passcode for both U.S.
and international callers is 27363175.
The Company’s supplemental information package for the current period
will also be available on the Company’s website under the “Investor
Relations” section.
About Medical Properties Trust, Inc.
Medical Properties Trust, Inc. is a Birmingham, Alabama based
self-advised real estate investment trust formed to capitalize on the
changing trends in healthcare delivery by acquiring and developing
net-leased healthcare facilities. MPT’s financing model allows hospitals
and other healthcare facilities to unlock the value of their underlying
real estate in order to fund facility improvements, technology upgrades,
staff additions and new construction. Facilities include acute care
hospitals, inpatient rehabilitation hospitals, long-term acute care
hospitals, and other medical and surgical facilities. For more
information, please visit the Company’s website at www.medicalpropertiestrust.com.
The statements in this press release that are forward looking are
based on current expectations and actual results or future events may
differ materially. Words such as "expects," "believes," "anticipates,"
"intends," "will," "should” and variations of such words and similar
expressions are intended to identify such forward-looking statements.
Forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause the actual results of the
Company or future events to differ materially from those expressed in or
underlying such forward-looking statements, including without
limitation: the capacity of the Company’s tenants to meet the terms of
their agreements; Normalized FFO per share; expected payout ratio, the
amount of acquisitions of healthcare real estate, if any; capital
markets conditions, the repayment of debt arrangements; statements
concerning the additional income to the Company as a result of ownership
interests in certain hospital operations and the timing of such income;
the restructuring of the Company’s investments in Monroe Hospital;
the payment of future dividends, if any; completion of additional debt
arrangement, and additional investments; national and economic,
business, real estate and other market conditions; the competitive
environment in which the Company operates; the execution of the
Company's business plan; financing risks; the Company's ability to
maintain its status as a REIT for federal income tax purposes;
acquisition and development risks; potential environmental and other
liabilities; and other factors affecting the real estate industry
generally or healthcare real estate in particular. For further
discussion of the factors that could affect outcomes, please refer to
the "Risk factors" section of the Company's Annual Report on Form 10-K
for the year ended December 31, 2013, and as updated by the Company’s
subsequently filed Quarterly Reports on Form 10-Q and other SEC filings.
Except as otherwise required by the federal securities laws, the Company
undertakes no obligation to update the information in this press release.
|
|
|
MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES
|
|
|
|
|
|
|
|
Consolidated Balance Sheets
|
|
|
|
|
|
|
|
|
|
June 30, 2014
|
|
December 31, 2013
|
|
Assets
|
|
(Unaudited)
|
|
(A)
|
|
Real estate assets
|
|
|
|
|
|
Land, buildings and improvements, and intangible lease assets
|
|
$
|
1,973,883,213
|
|
|
$
|
1,823,683,129
|
|
|
Construction in progress and other
|
|
|
52,375,733
|
|
|
|
41,771,499
|
|
|
Net investment in direct financing leases
|
|
|
434,310,776
|
|
|
|
431,024,228
|
|
|
Mortgage loans
|
|
|
385,100,144
|
|
|
|
388,756,469
|
|
|
Gross investment in real estate assets
|
|
|
2,845,669,866
|
|
|
|
2,685,235,325
|
|
|
Accumulated depreciation and amortization
|
|
|
(178,261,853
|
)
|
|
|
(159,776,091
|
)
|
|
Net investment in real estate assets
|
|
|
2,667,408,013
|
|
|
|
2,525,459,234
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
|
197,022,616
|
|
|
|
45,979,648
|
|
|
Interest and rent receivable
|
|
|
46,353,272
|
|
|
|
58,565,294
|
|
|
Straight-line rent receivable
|
|
|
51,192,748
|
|
|
|
45,828,685
|
|
|
Other assets
|
|
|
228,067,539
|
|
|
|
228,862,582
|
|
|
Total Assets
|
|
$
|
3,190,044,188
|
|
|
$
|
2,904,695,443
|
|
|
|
|
|
|
|
|
Liabilities and Equity
|
|
|
|
|
|
Liabilities
|
|
|
|
|
|
Debt, net
|
|
$
|
1,640,353,618
|
|
|
$
|
1,421,680,749
|
|
|
Accounts payable and accrued expenses
|
|
|
84,230,814
|
|
|
|
94,289,615
|
|
|
Deferred revenue
|
|
|
27,424,937
|
|
|
|
24,114,374
|
|
|
Lease deposits and other obligations to tenants
|
|
|
25,080,815
|
|
|
|
20,402,058
|
|
|
Total liabilities
|
|
|
1,777,090,184
|
|
|
|
1,560,486,796
|
|
|
|
|
|
|
|
|
Equity
|
|
|
|
|
|
Preferred stock, $0.001 par value. Authorized 10,000,000 shares;
no shares outstanding
|
|
|
-
|
|
|
|
-
|
|
|
Common stock, $0.001 par value. Authorized 250,000,000 shares;
issued and outstanding - 171,550,527 shares at June 30, 2014 and
161,309,725 shares at December 31, 2013
|
|
|
171,551
|
|
|
|
161,310
|
|
|
Additional paid in capital
|
|
|
1,750,808,870
|
|
|
|
1,618,054,133
|
|
|
Distributions in excess of net income
|
|
|
(330,074,847
|
)
|
|
|
(264,803,804
|
)
|
|
Accumulated other comprehensive income (loss)
|
|
|
(7,689,227
|
)
|
|
|
(8,940,649
|
)
|
|
Treasury shares, at cost
|
|
|
(262,343
|
)
|
|
|
(262,343
|
)
|
|
Total Equity
|
|
|
1,412,954,004
|
|
|
|
1,344,208,647
|
|
|
|
|
|
|
|
|
Total Liabilities and Equity
|
|
$
|
3,190,044,188
|
|
|
$
|
2,904,695,443
|
|
|
|
|
|
|
|
|
(A) Financials have been derived from the prior year
audited financials and include certain minor reclasses to be
consistent with the 2014 presentation.
|
|
|
|
|
|
|
|
MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated Statements of Income
|
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended
|
|
For the Six Months Ended
|
|
|
|
June 30, 2014
|
|
June 30, 2013
|
|
June 30, 2014
|
|
June 30, 2013
|
|
|
|
|
|
(A)
|
|
|
|
(A)
|
|
Revenues
|
|
|
|
|
|
|
|
|
|
Rent billed
|
|
$
|
45,927,570
|
|
|
$
|
31,024,222
|
|
|
$
|
88,889,236
|
|
|
$
|
62,527,678
|
|
|
Straight-line rent
|
|
|
3,178,229
|
|
|
|
2,776,592
|
|
|
|
5,366,552
|
|
|
|
5,468,147
|
|
|
Income from direct financing leases
|
|
|
12,263,376
|
|
|
|
9,229,987
|
|
|
|
24,478,765
|
|
|
|
17,986,458
|
|
|
Interest and fee income
|
|
|
15,191,292
|
|
|
|
14,093,034
|
|
|
|
30,914,569
|
|
|
|
28,755,304
|
|
|
Total revenues
|
|
|
76,560,467
|
|
|
|
57,123,835
|
|
|
|
149,649,122
|
|
|
|
114,737,587
|
|
|
Expenses
|
|
|
|
|
|
|
|
|
|
Real estate depreciation and amortization
|
|
|
12,441,777
|
|
|
|
8,642,893
|
|
|
|
26,131,379
|
|
|
|
17,112,093
|
|
|
Impairment charges
|
|
|
29,631,432
|
|
|
|
-
|
|
|
|
50,127,895
|
|
|
|
-
|
|
|
Property-related
|
|
|
(37,906
|
)
|
|
|
649,281
|
|
|
|
700,397
|
|
|
|
1,062,003
|
|
|
Acquisition expenses
|
|
|
2,534,784
|
|
|
|
2,087,903
|
|
|
|
3,046,803
|
|
|
|
2,278,452
|
|
|
General and administrative
|
|
|
8,205,885
|
|
|
|
7,110,537
|
|
|
|
17,164,674
|
|
|
|
14,876,486
|
|
|
Total operating expenses
|
|
|
52,775,972
|
|
|
|
18,490,614
|
|
|
|
97,171,148
|
|
|
|
35,329,034
|
|
|
Operating income
|
|
|
23,784,495
|
|
|
|
38,633,221
|
|
|
|
52,477,974
|
|
|
|
79,408,553
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest and other income (expense)
|
|
|
(23,947,079
|
)
|
|
|
(13,488,033
|
)
|
|
|
(45,389,616
|
)
|
|
|
(28,645,399
|
)
|
|
Income tax (expense) benefit
|
|
|
(40,434
|
)
|
|
|
(114,833
|
)
|
|
|
16,890
|
|
|
|
(167,080
|
)
|
|
Income (loss) from continuing operations
|
|
|
(203,018
|
)
|
|
|
25,030,355
|
|
|
|
7,105,248
|
|
|
|
50,596,074
|
|
|
Income (loss) from discontinued operations
|
|
|
-
|
|
|
|
2,374,053
|
|
|
|
(1,500
|
)
|
|
|
3,018,459
|
|
|
Net income (loss)
|
|
|
(203,018
|
)
|
|
|
27,404,408
|
|
|
|
7,103,748
|
|
|
|
53,614,533
|
|
|
Net income (loss) attributable to non-controlling interests
|
|
|
-
|
|
|
|
(56,582
|
)
|
|
|
(65,472
|
)
|
|
|
(110,215
|
)
|
|
Net income (loss) attributable to MPT common stockholders
|
|
$
|
(203,018
|
)
|
|
$
|
27,347,826
|
|
|
$
|
7,038,276
|
|
|
$
|
53,504,318
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per common share - basic:
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations
|
|
$
|
-
|
|
|
$
|
0.16
|
|
|
$
|
0.04
|
|
|
$
|
0.35
|
|
|
Income (loss) from discontinued operations
|
|
|
-
|
|
|
|
0.02
|
|
|
|
-
|
|
|
|
0.02
|
|
|
Net income (loss) attributable to MPT common stockholders
|
|
$
|
-
|
|
|
$
|
0.18
|
|
|
$
|
0.04
|
|
|
$
|
0.37
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per common share - diluted:
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations
|
|
$
|
-
|
|
|
$
|
0.16
|
|
|
$
|
0.04
|
|
|
$
|
0.34
|
|
|
Income (loss) from discontinued operations
|
|
|
-
|
|
|
|
0.02
|
|
|
|
-
|
|
|
|
0.02
|
|
|
Net income (loss) attributable to MPT common stockholders
|
|
$
|
-
|
|
|
$
|
0.18
|
|
|
$
|
0.04
|
|
|
$
|
0.36
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends declared per common share
|
|
$
|
0.21
|
|
|
$
|
0.20
|
|
|
$
|
0.42
|
|
|
$
|
0.40
|
|
|
|
|
|
|
|
.
|
|
|
|
|
|
.
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding - basic
|
|
|
171,718,449
|
|
|
|
149,508,958
|
|
|
|
167,845,813
|
|
|
|
144,927,768
|
|
|
Weighted average shares outstanding - diluted
|
|
|
172,368,987
|
|
|
|
151,055,855
|
|
|
|
168,458,784
|
|
|
|
146,291,083
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(A) Financials have been restated to reclass the
operating results of certain properties sold after the 2013 second
quarter to discontinued operations.
|
|
|
|
MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES
|
|
Reconciliation of Net Income to Funds From Operations
|
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended
|
For the Six Months Ended
|
|
|
|
June 30, 2014
|
|
June 30, 2013
|
|
June 30, 2014
|
|
June 30, 2013
|
|
|
|
|
|
(A)
|
|
|
|
(A)
|
|
FFO information:
|
|
|
|
|
|
|
|
|
|
Net income (loss) attributable to MPT common stockholders
|
|
$
|
(203,018
|
)
|
|
$
|
27,347,826
|
|
|
$
|
7,038,276
|
|
|
$
|
53,504,318
|
|
|
Participating securities' share in earnings
|
|
|
(195,124
|
)
|
|
|
(179,263
|
)
|
|
|
(404,494
|
)
|
|
|
(372,325
|
)
|
|
Net income (loss), less participating securities' share in earnings
|
|
$
|
(398,142
|
)
|
|
$
|
27,168,563
|
|
|
$
|
6,633,782
|
|
|
$
|
53,131,993
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization:
|
|
|
|
|
|
|
|
|
|
Continuing operations
|
|
|
12,441,777
|
|
|
|
8,642,893
|
|
|
|
26,131,379
|
|
|
|
17,112,093
|
|
|
Discontinued operations
|
|
|
-
|
|
|
|
74,751
|
|
|
|
-
|
|
|
|
252,701
|
|
|
Real estate impairment charges
|
|
|
5,974,400
|
|
|
|
-
|
|
|
|
5,974,400
|
|
|
|
-
|
|
|
Gain on sale of real estate
|
|
|
-
|
|
|
|
(2,054,229
|
)
|
|
|
-
|
|
|
|
(2,054,229
|
)
|
|
Funds from operations
|
|
$
|
18,018,035
|
|
|
$
|
33,831,978
|
|
|
$
|
38,739,561
|
|
|
$
|
68,442,558
|
|
|
|
|
|
|
|
|
|
|
|
|
Write-off straight line rent
|
|
|
-
|
|
|
|
-
|
|
|
|
950,338
|
|
|
|
-
|
|
|
Debt refinancing costs
|
|
|
290,635
|
|
|
|
-
|
|
|
|
290,635
|
|
|
|
-
|
|
|
Loan and other impairment charges
|
|
|
23,657,032
|
|
|
|
-
|
|
|
|
44,153,495
|
|
|
|
-
|
|
|
Acquisition costs
|
|
|
2,534,784
|
|
|
|
2,087,903
|
|
|
|
3,046,803
|
|
|
|
2,278,452
|
|
|
Normalized funds from operations
|
|
$
|
44,500,486
|
|
|
$
|
35,919,881
|
|
|
$
|
87,180,832
|
|
|
$
|
70,721,010
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based compensation
|
|
|
2,075,576
|
|
|
|
2,285,050
|
|
|
|
4,118,986
|
|
|
|
4,203,905
|
|
|
Debt costs amortization
|
|
|
1,144,560
|
|
|
|
855,417
|
|
|
|
2,193,282
|
|
|
|
1,752,149
|
|
|
Additional rent received in advance (B)
|
|
|
(300,000
|
)
|
|
|
(300,000
|
)
|
|
|
(600,000
|
)
|
|
|
(600,000
|
)
|
|
Straight-line rent revenue and other
|
|
|
(4,830,525
|
)
|
|
|
(4,012,026
|
)
|
|
|
(9,533,392
|
)
|
|
|
(7,904,654
|
)
|
|
Adjusted funds from operations
|
|
$
|
42,590,097
|
|
|
$
|
34,748,322
|
|
|
$
|
83,359,708
|
|
|
$
|
68,172,410
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Per diluted share data:
|
|
|
|
|
|
|
|
|
|
Net income (loss), less participating securities' share in earnings
|
|
$
|
-
|
|
|
$
|
0.18
|
|
|
$
|
0.04
|
|
|
$
|
0.36
|
|
|
Depreciation and amortization:
|
|
|
|
|
|
|
|
|
|
Continuing operations
|
|
|
0.07
|
|
|
|
0.06
|
|
|
|
0.16
|
|
|
|
0.12
|
|
|
Discontinued operations
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
Real estate impairment charges
|
|
|
0.03
|
|
|
|
-
|
|
|
|
0.03
|
|
|
|
-
|
|
|
Gain on sale of real estate
|
|
|
-
|
|
|
|
(0.02
|
)
|
|
|
-
|
|
|
|
(0.01
|
)
|
|
Funds from operations
|
|
$
|
0.10
|
|
|
$
|
0.22
|
|
|
$
|
0.23
|
|
|
$
|
0.47
|
|
|
|
|
|
|
|
|
|
|
|
|
Write-off straight line rent
|
|
|
-
|
|
|
|
-
|
|
|
|
0.01
|
|
|
|
-
|
|
|
Debt refinancing costs
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
Loan and other impairment charges
|
|
|
0.14
|
|
|
|
-
|
|
|
|
0.26
|
|
|
|
-
|
|
|
Acquisition costs
|
|
|
0.02
|
|
|
|
0.02
|
|
|
|
0.02
|
|
|
|
0.01
|
|
|
Normalized funds from operations
|
|
$
|
0.26
|
|
|
$
|
0.24
|
|
|
$
|
0.52
|
|
|
$
|
0.48
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based compensation
|
|
|
0.01
|
|
|
|
0.02
|
|
|
|
0.02
|
|
|
|
0.03
|
|
|
Debt costs amortization
|
|
|
0.01
|
|
|
|
-
|
|
|
|
0.01
|
|
|
|
0.01
|
|
|
Additional rent received in advance (B)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
Straight-line rent revenue and other
|
|
|
(0.03
|
)
|
|
|
(0.03
|
)
|
|
|
(0.06
|
)
|
|
|
(0.05
|
)
|
|
Adjusted funds from operations
|
|
$
|
0.25
|
|
|
$
|
0.23
|
|
|
$
|
0.49
|
|
|
$
|
0.47
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(A) Financials have been restated to reclass the
operating results of certain properties sold after the 2013 second
quarter to discontinued operations.
|
|
|
|
|
|
|
|
|
|
|
|
(B )Represents additional rent from one tenant in
advance of when we can recognize as revenue for accounting
purposes.
|
|
This additional rent is being recorded to revenue on a
straight-line basis over the lease life.
|
Investors and analysts following the real estate industry utilize funds
from operations, or FFO, as a supplemental performance measure. FFO,
reflecting the assumption that real estate asset values rise or fall
with market conditions, principally adjusts for the effects of GAAP
depreciation and amortization of real estate assets, which assumes that
the value of real estate diminishes predictably over time. We compute
FFO in accordance with the definition provided by the National
Association of Real Estate Investment Trusts, or NAREIT, which
represents net income (loss) (computed in accordance with GAAP),
excluding gains (losses) on sales of real estate and impairment charges
on real estate assets, plus real estate depreciation and amortization
and after adjustments for unconsolidated partnerships and joint ventures.
In addition to presenting FFO in accordance with the NAREIT definition,
we also disclose normalized FFO,which adjusts FFO for items that relate
to unanticipated or non-core events or activities or accounting changes
that, if not noted, would make comparison to prior period results and
market expectations less meaningful to investors and analysts. We
believe that the use of FFO, combined with the required GAAP
presentations, improves the understanding of our operating results among
investors and the use of normalized FFO makes comparisons of our
operating results with prior periods and other companies more
meaningful. While FFO and normalized FFO are relevant and widely used
supplemental measures of operating and financial performance of REITs,
they should not be viewed as a substitute measure of our operating
performance since the measures do not reflect either depreciation and
amortization costs or the level of capital expenditures and leasing
costs necessary to maintain the operating performance of our properties,
which can be significant economic costs that could materially impact our
results of operations. FFO and normalized FFO should not be considered
an alternative to net income (loss) (computed in accordance with GAAP)
as indicators of our financial performance or to cash flow from
operating activities (computed in accordance with GAAP) as an indicator
of our liquidity.
We calculate adjusted funds from operations, or AFFO, by subtracting
from or adding to normalized FFO (i) unbilled rent revenue, (ii)
non-cash share-based compensation expense, and (iii) amortization of
deferred financing costs. AFFO is an operating measurement that we use
to analyze our results of operations based on the receipt, rather than
the accrual, of our rental revenue and on certain other adjustments. We
believe that this is an important measurement because our leases
generally have significant contractual escalations of base rents and
therefore result in recognition of rental income that is not collected
until future periods, and costs that are deferred or are non-cash
charges. Our calculation of AFFO may not be comparable to AFFO or
similarly titled measures reported by other REITs. AFFO should not be
considered as an alternative to net income (calculated pursuant to GAAP)
as an indicator of our results of operations or to cash flow from
operating activities (calculated pursuant to GAAP) as an indicator of
our liquidity.

Source: Medical Properties Trust, Inc.
Medical Properties Trust, Inc.
Tim Berryman, 205-397-8589
Director
– Investor Relations
tberryman@medicalpropertiestrust.com